Abstract
Nelson syndrome is a rare cause of generalized mucocutaneous hyperpigmentation. Its clinical manifestations are due to excessive secretion of adrenocorticotropic hormone from a pituitary adenoma, which develops after bilateral therapeutic adrenalectomy. As this operation has fallen into disuse, Nelson syndrome is now extremely rare and difficult to recognize. We present a very severe case of generalized hyperpigmentation due to Nelson syndrome in a 37-year-old woman.
MeSH terms
-
Adenoma / complications
-
Adenoma / diagnosis
-
Adenoma / drug therapy
-
Adenoma / etiology*
-
Adenoma / surgery
-
Adrenalectomy / adverse effects*
-
Adult
-
Cabergoline
-
Combined Modality Therapy
-
Dicarboxylic Acids / therapeutic use
-
Ergolines / therapeutic use
-
Female
-
Hormone Replacement Therapy
-
Humans
-
Hydrocortisone / therapeutic use
-
Hypophysectomy
-
Nelson Syndrome / diagnosis
-
Nelson Syndrome / drug therapy
-
Nelson Syndrome / etiology*
-
Nelson Syndrome / pathology
-
Nelson Syndrome / surgery
-
Neoplasms, Multiple Primary
-
Peptides, Cyclic / therapeutic use
-
Pituitary ACTH Hypersecretion / drug therapy
-
Pituitary ACTH Hypersecretion / etiology
-
Pituitary ACTH Hypersecretion / surgery
-
Pituitary Apoplexy / complications
-
Pituitary Apoplexy / surgery
-
Pituitary Neoplasms / complications
-
Pituitary Neoplasms / surgery
-
Radiosurgery
-
Somatostatin / analogs & derivatives
-
Somatostatin / therapeutic use
-
Thyroxine / therapeutic use
Substances
-
Dicarboxylic Acids
-
Ergolines
-
Peptides, Cyclic
-
lanreotide
-
Somatostatin
-
azelaic acid
-
Cabergoline
-
Thyroxine
-
Hydrocortisone